期刊
CELLULAR SIGNALLING
卷 27, 期 10, 页码 2054-2067出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2015.07.017
关键词
Syndecan-1; Malignant mesothelioma; Transcription factor; Mitogen-activated protein kinase (MAPK); Receptor tyrosine kinase
类别
资金
- AFA Insurance [120263]
- Swedish Research Council [K2012-99X-21999-01-3]
- Swedish Cancer Foundation [130491]
- French National Agency for Research (ANR) [ANR-12-SVSE-008]
Syndecan-1 is a proteoglycan that acts as co-receptor through its heparan sulfate (HS) chains and plays important roles in cancer. HS chains are highly variable in length and sulfation pattern. This variability is enhanced by the SULF1/2 enzymes, which remove 6-O-sulfates from HS. We used malignant mesothelioma, an aggressive tumor with poor prognosis, as a model and demonstrated that syndecan-1 over-expression down-regulates SULF1 and alters the HS biosynthetic machinery. Biochemical characterization revealed a 2.7-fold reduction in HS content upon syndecan-1 over-expression, but an overall increase in sulfation. Consistent with low SULF1 levels, trisulfated disaccharides increased 2.5-fold. ERK1/2 activity was enhanced 6-fold. Counteracting ERK activation, Akt, WNK1, and c-Jun were inhibited. The net effect of these changes manifested in G1 cell cycle arrest. Studies of pleural effusions showed that SULF1 levels are lower in pleural malignancies compared to benign conditions and inversely correlate with the amounts of syndecan-1, suggesting important roles for syndecan-1 and SULF1 in malignant mesothelioma. (C) 2015 The Authors. Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据